PharmaJet

PharmaJet is a private medical technology company pioneering needle-free injection systems designed to enhance the delivery of vaccines and therapeutics. Its core platform offers potential benefits such as reduced needle-stick injuries, improved patient acceptance, and precise intradermal delivery that can lower required doses. The company targets partnerships with pharmaceutical firms, governments, and global health organizations to integrate its devices into vaccination campaigns and therapeutic regimens. While facing competition from other needle-free technologies and traditional syringe manufacturers, PharmaJet has secured key partnerships and regulatory clearances to advance its commercial footprint.

Needle-free injection systems using a spring-powered mechanism to deliver a precise, high-pressure stream of liquid medication intradermally or intramuscularly.

PharmaJet competes with other needle-free injector companies (e.g., Portal Instruments, Injex), traditional syringe manufacturers (BD, Gerresheimer), and emerging technologies like microneedle patches. Its primary differentiation is the WHO Prequalification for intradermal delivery and a focus on rugged, portable devices for global health settings.